Therapeutic Implications of Diabetes in Cardiovascular Disease

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Therapeutics

• Publication date

  2009-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MJT.0b013e31815db924PMID 19940606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Institute of Diabetes and Digestive and Kidney Diseases

  2008cited by this paper
• Rosiglitazone Evaluated for Cardiovascular Outcomes—An Interim Analysis

  2008cited by this paper
• Rosiglitazone and cardiovascular risk.

  2007cited by this paper
• Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

  2007cited by this paper
• Rosiglitazone and cardiovascular risk.

  2007cited by this paper
• Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

  2007cited by this paper
• Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: metaanalysis of randomised controlled trials

  2006cited by this paper
• Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.

  2006cited by this paper
• Frequency-dependent contractile response of isolated cardiac trabeculae under hypo-, normo-, and hyperthermic conditions.

  2006cited by this paper
• Effect of Rosiglitazone Treatment on Plaque Inflammation and Collagen Content in Nondiabetic Patients: Data From a Randomized Placebo-Controlled Trial

  2006cited by this paper
• Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000.

  2006cited by this paper
• Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms

  2006cited by this paper
• Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study.

  2006cited by this paper
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

  2006cited by this paper
• Disorders of glucose metabolism in acute stroke patients: an underrecognized problem.

  2006cited by this paper
• Stressed out about obesity and insulin resistance

  2006cited by this paper
• Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound.

  2006cited by this paper
• Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

  2006cited by this paper
• Physical Activity/Exercise and Type 2 Diabetes

  2006cited by this paper
• Visceral Fat Is an Independent Predictor of All‐cause Mortality in Men

  2006cited by this paper
• Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk

  2006cited by this paper
• Adipokines: molecular links between obesity and atheroslcerosis.

  2005cited by this paper
• Thiazolidinediones, Metformin, and Outcomes in Older Patients With Diabetes and Heart Failure: An Observational Study

  2005cited by this paper
• Inflammation, stress, and diabetes.

  2005cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Pioglitazone Decreases Carotid Intima-Media Thickness Independently of Glycemic Control in Patients With Type 2 Diabetes Mellitus: Results From a Controlled Randomized Study

  2005cited by this paper
• Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project.

  2004cited by this paper
• Plasma adiponectin levels and risk of myocardial infarction in men.

  2004cited by this paper
• Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity*

  2004cited by this paper
• Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial

  2004cited by this paper
• Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors.

  2004cited by this paper
• Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus.

  2004cited by this paper
• Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

  2004cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

  2003cited by this paper
• Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

  2003cited by this paper
• Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.

  2003cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.

  2002cited by this paper
• Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes.

  2002cited by this paper
• A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.

  2002cited by this paper
• Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

  2002cited by this paper
• Diabetes Therapeutics News

  2002cited by this paper
• Insulin resistance and cardiovascular disease.

  2001cited by this paper
• Insulin resistance and cardiovascular disease.

  2001cited by this paper
• Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes.

  2001cited by this paper
• Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.

  1999cited by this paper
• Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria

  1999cited by this paper
• Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes.

  1998cited by this paper
• Case-control study of sudden infant death syndrome in Scotland, 1992-5

  1997cited by this paper

• The effect of metformin on memory retention of inhibitory avoidance learning in streptozotocin-induced rat model of alzheimer’s disease

  2015cites this paper
• Environmental Endocrine Disruption of Energy Metabolism and Cardiovascular Risk

  2014cites this paper
• Tight Glycemic Control and Cardiovascular Effects in Type 2 Diabetic Patients

  2014cites this paper
• Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice.

  2012cites this paper
• Measurement Techniques for Insulin Sensitivity

  2012cites this paper
• Alteraciones vasculares pulmonares e hipertensión pulmonar en modelos de diabetes

  2012cites this paper
• Pulmonary arterial dysfunction in insulin resistant obese Zucker rats

  2011cites this paper
• Endurance and resistance training lowers C-reactive protein in young, healthy females.

  2011cites this paper
• Guía para seleccionar el tratamiento farmacológico en diabetes 2

  2010cites this paper
• The role of protein kinase C in the pathogenesis of insulin resistance and its complications

  2010cites this paper